TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discoveryPromega UK, Southampton, UK. (10 February 2026) Promega Corporation is launching a new live-cell ...
Using a BRET-based shift assay, the system quantifies target engagement in intact cells, including weak interactions, broadening drug discovery workflows and improving early-stage confidence in ...
Promega Corporation has introduced a new platform designed to help drug discovery scientists study some of the most challenging protein targets in living cells, enabling earlier and more reliable ...
Products released at this year's meeting covered a broad range of applications from sustainable labware to protein assays to instruments.
According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results